MB 1
BULLETS
Free CME
Join now
Please confirm topic selection

Are you sure you want to trigger topic in your Anconeus AI algorithm?

Please confirm action

You are done for today with this topic.

Would you like to start learning session with this topic items scheduled for future?

Review Question - QID 214372

Lipid Lowering Drugs HMG-CoA Reductase Inhibitors Mechanism QID: 214372 (M1.OMB.1)
In scope icon M 3 A
QID 214372 (Type "214372" in App Search)
A 55-year-old man presents to the emergency department for slurred speech and weakness affecting his left upper and lower extremities. His symptoms began approximately 2 hours ago and have not improved. A CT scan of the head is negative for an intracranial hemorrhage or space-occupying lesion, and he is started on alteplase. He is admitted to the hospital for further monitoring. In addition to aspirin, he is started on a second agent for secondary stroke prevention. Which of the following is the mechanism of action of this second agent?
Type in at least one full word to see suggestions list